In a session moderated by Phillip Sharp, professor at MIT's Institute for Integrative Cancer Research, principal investigators of the five Stand Up to Cancer grant-funded Dream Teams, researchers shared their progress. With SU2C, "we were challenged for finding teams out of a process that solicited — across the country — new ideas. And we used several criteria to look at these teams," Sharp told attendees of the American Association for Cancer Research's annual meeting. "Innovation: what could be done new, now?

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

Church Opens Up

Technostalgia

Arsenic Adaptation

This Week in PNAS

Big Pregnancy Data

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.